CG Oncology, Inc. (CGON)
72.59
-0.05
(-0.07%)
USD |
NASDAQ |
Nov 11, 16:00
72.59
0.00 (0.00%)
After-Hours: 18:52
CG Oncology Price : 72.59 for Nov. 11, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 10, 2026 | 73.84 | 75.00 | 71.26 | 72.64 | 821633.0 |
| Nov 09, 2026 | 77.19 | 77.99 | 72.41 | 74.74 | 1.512M |
| Nov 06, 2026 | 66.49 | 80.03 | 66.17 | 75.99 | 3.662M |
| Nov 05, 2026 | 67.34 | 67.34 | 64.16 | 64.80 | 931579.0 |
| Nov 04, 2026 | 66.10 | 67.88 | 63.16 | 67.71 | 1.394M |
| Nov 03, 2026 | 62.52 | 65.78 | 62.35 | 64.06 | 724759.0 |
| Nov 02, 2026 | 64.18 | 64.68 | 61.01 | 61.96 | 1.280M |
| Oct 30, 2026 | 63.00 | 65.54 | 60.62 | 64.68 | 870332.0 |
| Oct 29, 2026 | 64.53 | 65.74 | 63.08 | 63.47 | 782618.0 |
| Oct 28, 2026 | 62.53 | 64.12 | 62.30 | 63.96 | 944302.0 |
| Oct 27, 2026 | 61.46 | 64.13 | 59.96 | 62.94 | 709343.0 |
| Oct 26, 2026 | 61.76 | 62.80 | 61.06 | 61.56 | 880160.0 |
| Oct 23, 2026 | 62.36 | 62.36 | 59.86 | 61.71 | 1.065M |
| Oct 22, 2026 | 61.95 | 63.18 | 61.40 | 62.54 | 579520.0 |
| Oct 21, 2026 | 62.43 | 63.57 | 61.27 | 62.24 | 530138.0 |
| Oct 20, 2026 | 60.16 | 62.71 | 60.16 | 61.93 | 766680.0 |
| Oct 19, 2026 | 60.44 | 61.25 | 59.22 | 59.96 | 1.215M |
| Oct 16, 2026 | 61.86 | 62.00 | 59.37 | 59.85 | 1.080M |
| Oct 15, 2026 | 62.70 | 63.24 | 60.96 | 61.86 | 1.186M |
| Oct 14, 2026 | 62.48 | 63.44 | 61.27 | 61.84 | 1.100M |
| Oct 13, 2026 | 61.92 | 63.85 | 61.52 | 62.40 | 1.189M |
| Oct 12, 2026 | 63.43 | 64.15 | 62.68 | 63.13 | 660633.0 |
| Oct 09, 2026 | 62.97 | 65.18 | 62.88 | 63.82 | 516536.0 |
| Oct 08, 2026 | 61.65 | 63.71 | 61.11 | 63.26 | 910307.0 |
| Oct 07, 2026 | 62.68 | 63.64 | 61.90 | 62.38 | 621821.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 49.35 |
| Oncolytics Biotech, Inc. | 0.4069 |
| Sangamo Therapeutics, Inc. | 0.11 |
| Sarepta Therapeutics, Inc. | 16.67 |
| Anixa Biosciences, Inc. | 2.83 |
Price Related Metrics
| PS Ratio | 1005.64 |
| PEG Ratio | -0.6675 |
| Price to Book Value | 6.541 |
| Earnings Yield | -3.81% |
| Market Cap | 6.482B |
| PEGY Ratio | -0.6675 |